Skip to Content
Søk Menu

Does JAKi Increase the Risk of Cancer in Patients with RA?

Do we need to be aware of cancer risk when treating janus kinase inhibitors (JAKi)? Let Rasmus Westermann, MD, present his study investigating cancer risk in patients with rheumatoid arthritis (RA) treated with JAKi compared to biologics.
Rasmus Westermann

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relatert innhold

Implementation of Early Specialized Palliative Care in an Oncologic Department

/ Katrine Rahbek Schønnemann / Sabine Ute Alice Gill
Kreft
Petter Brandal

Insights from Onkologisk Forum 2023

/ Petter Brandal
KreftOnkologiskForum23 Play the Video 5:16
Bettina Kulle Andreassen

The Value of Real-World Data in Clinical Oncological Research

/ Bettina Kulle Andreassen
KreftOnkologiskForum23 Play the Video 3:02
Petter Brandal

Proton vs Photon Radiotherapy for Brain Tumors in Patients with Diffuse Grade 2 and 3 Gliomas

/ Petter Brandal
KreftOnkologiskForum23 Play the Video 3:02
Kenneth Jensen

Proton Therapy for Head and Neck Cancer

/ Kenneth Jensen
KreftOnkologiskForum23 Play the Video 4:11
Giuseppe Curigliano

Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer Treatment

/ Giuseppe Curigliano
BrystkreftKreft Play the Video 4:28

Pneumococcal Vaccination of Patients with Autoimmune Inflammatory Rheumatic Diseases

/ Sofie Larsen Rasmussen
Revmatoid artrittVaksinasjon
Rasmus Westermann

Cancer Risk in Rheumatoid Arthritis Patients Treated with Non-TNFi bDMARDs

/ Rasmus Westermann
KreftRevmatoid artrittSCR23 Play the Video 7:28
Espen Haavardsholm

Rheumatoid Arthritis – What Is New From SCR23?

/ Espen Haavardsholm
Revmatoid artrittSCR23 Play the Video 03:17
Back to top